Preserved Liver Function in BCLC Staging
In the Barcelona Clinic Liver Cancer (BCLC) staging system, "preserved liver function" is specifically defined as Child-Pugh class A without clinically detectable ascites. 1, 2
Precise Definition
The EASL guidelines explicitly state that preserved liver function refers to:
- Child-Pugh class A (score 5-6 points) 2
- Absence of ascites on clinical examination or imaging 1, 2
- This definition applies to all BCLC treatment stages except liver transplantation, which is specifically indicated for patients with decompensated cirrhosis 2
Clinical Implications for Treatment Eligibility
Preserved liver function is the prerequisite for optimal outcomes across BCLC stages 0, A, B, and C, determining whether patients can tolerate curative resection, ablation, TACE, or systemic therapy. 2
Key Parameters Beyond Child-Pugh A:
- Portal hypertension assessment is critical even when Child-Pugh is class A, as clinically significant portal hypertension (hepatic venous pressure gradient >10 mmHg, esophageal varices, or platelet count <100,000/μL) contraindicates surgical resection despite preserved Child-Pugh status 2, 3
- MELD score <10 is recommended for optimal surgical candidacy, with expected perioperative mortality <3% 2
- Absence of hepatic encephalopathy and normal or near-normal bilirubin are implicit in the Child-Pugh A classification 3
Common Pitfalls to Avoid
Do not equate "preserved liver function" with Child-Pugh B. The Korean guidelines clarify that while Child-Pugh B patients may be considered for some treatments, the BCLC definition of "preserved" specifically requires Child-Pugh A. 1 Child-Pugh B patients, particularly those with scores ≥8, may experience detrimental effects from treatments like TACE. 4
Ascites is an absolute exclusion criterion even if minimal or only detected on imaging—any ascites disqualifies a patient from having "preserved" liver function per BCLC criteria. 1, 2
Why This Definition Matters
The 2022 BCLC update maintains this strict definition because:
- Child-Pugh A patients without ascites have sufficient hepatic reserve to tolerate treatment-related liver injury 1
- Approximately 80% of newly diagnosed HCC presents with Child-Pugh A disease, making this the target population for curative and palliative interventions 5
- Treatment outcomes deteriorate sharply when liver function is compromised beyond these thresholds—median survival for Child-Pugh C patients is <4 months regardless of tumor burden 2, 5
For surgical resection specifically, preserved liver function must also include absence of clinically significant portal hypertension, as this independently predicts poor postoperative outcomes even in Child-Pugh A patients. 2, 5